Video

Dr. Ligibel on Patient Education to Avoid Breast Cancer Recurrence

Jennifer Ligibel, MD, senior physician, Susan F. Smith Center for Women's Cancer at the Dana-Farber Cancer Institute, associate professor of medicine, Harvard Medical School, discusses the resources available for patients to educate themselves on avoiding breast cancer recurrence.

Jennifer Ligibel, MD, senior physician, Susan F. Smith Center for Women’s Cancer at Dana-Farber Cancer Institute, associate professor of medicine, Harvard Medical School, discusses resources available for patients to educate themselves on avoiding breast cancer recurrence.

There are a number of different organizations that create guidelines on physical activity, nutrition, and body weight management for cancer survivors, Ligibel says. For the last 10 years, the American Cancer Society has provided information on what patients should be eating and how much exercise they should get after a diagnosis. The National Comprehensive Cancer Network has also provided nutrition-based insight in its survivorship guidelines. Thirdly, ASCO has created an initiative on obesity, which is geared toward helping patients understand these connections exist. Studies have shown, Ligibel adds, that while most people are aware of tobacco/alcohol connections to cancer risk, most don’t know that obesity could have an impact.

Ligibel adds that this is important because many patients are unaware of the safe types of physical activity after undergoing months of treatment.

Related Videos
Alan Tan, MD, genitourinary oncology and melanoma specialist, Vanderbilt-Ingram Cancer Center; associate professor, medicine, Division of Hematology Oncology, Vanderbilt University Medical Center
Zosia Piotrowska, MD, MHS, instructor, Harvard Medical School; medical oncologist, Massachusetts General Hospital
Bartosz Chmielowski, MD
Raza Hoda, MD, FASCP
Armin Ghobadi, MD, professor, medicine, Oncology, Section of Bone Marrow Transplant; clinical director, Center for Gene and Cellular Immunotherapy, Siteman Cancer Center, Washington University
Timothy S. Fenske, MD, MS
Yair Lotan, MD, professor, urology, chief, urologic oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center; medical director, Urology Clinic, UT Southwestern and Parkland Health and Hospital System
Roxana S. Dronca, MD, discusses the FDA’s approval of subcutaneous nivolumab across solid tumor indications.
Craig Eckfeldt, MD
Whitney Goldsberry, MD